Paul E. Verweij
Impact in
- Infectious Diseases top 0.01%
- Antifungal resistance and susceptibility
- Small Animals top 0.01%
- Infectious Diseases and Mycology
Papers in
-
- Antifungal resistance and susceptibility 383
- Epidemiology 260
- Fungal Infections and Studies 224
- Nail Diseases and Treatments 35
- Pneumocystis jirovecii pneumonia detection and treatment 25
- Co-authors
- Willem J. G. Melchers (127 shared papers)Jacques F. Meis (122 shared papers)Johan W. Mouton (56 shared papers)Eveline Snelders (23 shared papers)J. Peter Donnelly (26 shared papers)Adilia Warris (42 shared papers)Joseph Meletiadis (31 shared papers)Roger J. M. Brüggemann (46 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (61 papers)Journal of Clinical Microbiology (40 papers)Medical Mycology (28 papers)Journal of Antimicrobial Chemotherapy (25 papers)Clinical Infectious Diseases (21 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Paul E. Verweij
486 papers receiving 24.6k citations
Paul E. Verweij's Hit Papers
Peers
Comparison fields: 5 of 185
- Infectious Diseases 18.4k
- Small Animals 3.3k
- Epidemiology 13.7k
- Cell Biology 4.8k
- Applied Microbiology and Biotechnology 297
Countries citing papers authored by Paul E. Verweij
This map shows the geographic impact of Paul E. Verweij's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Verweij with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Verweij more than expected).
Fields of papers citing papers by Paul E. Verweij
This network shows the impact of papers produced by Paul E. Verweij. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Verweij. The network helps show where Paul E. Verweij may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul E. Verweij, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 498 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tackling the emerging threat of antifungal resistance to human health Hit paper breakdown → | 2022 | 675 |
| 2 | Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism Hit paper breakdown → | 2008 | 568 |
| 3 | EUCAST Definitive Document EDef 7.1: method for the determination of broth dilution MICs of antifungal agents for fermentative yeasts Hit paper breakdown → | 2008 | 549 |
| 4 | Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use? Hit paper breakdown → | 2009 | 464 |
| 5 | Azole Resistance in Aspergillus fumigatus : Can We Retain the Clinical Use of Mold-Active Antifungal Azoles? Hit paper breakdown → | 2015 | 434 |
| 6 | 2007 | 389 | |
| 7 | 2004 | 366 | |
| 8 | Clinical Implications of Azole Resistance inAspergillus fumigatus, the Netherlands, 2007–2009 Hit paper breakdown → | 2011 | 362 |
| 9 | 2009 | 341 | |
| 10 | 2009 | 332 | |
| 11 | 2012 | 324 | |
| 12 | 2008 | 292 | |
| 13 | 2013 | 259 | |
| 14 | 2016 | 236 | |
| 15 | 2003 | 227 | |
| 16 | 2018 | 220 | |
| 17 | 2012 | 219 | |
| 18 | 2007 | 214 | |
| 19 | 2002 | 214 | |
| 20 | 2000 | 210 |
About Paul E. Verweij
Paul E. Verweij is a scholar working on Infectious Diseases, Epidemiology, Cell Biology, Small Animals and Plant Science, having authored 498 papers that have together received 25.2k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (383 papers), Fungal Infections and Studies (224 papers), Plant Pathogens and Fungal Diseases (98 papers), Infectious Diseases and Mycology (85 papers), Mycotoxins in Agriculture and Food (42 papers), Nail Diseases and Treatments (35 papers), Pneumocystis jirovecii pneumonia detection and treatment (25 papers) and Fungal Biology and Applications (23 papers). The work is most often cited by research in Infectious Diseases (18.4k citations), Small Animals (3.3k citations), Epidemiology (13.7k citations), Cell Biology (4.8k citations) and Applied Microbiology and Biotechnology (297 citations). Paul E. Verweij has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Willem J. G. Melchers, Jacques F. Meis, Johan W. Mouton, Eveline Snelders, J. Peter Donnelly, Adilia Warris, Joseph Meletiadis, Roger J. M. Brüggemann, Monique A. S. H. Mennink‐Kersten and Antonius J. M. M. Rijs. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Medical Mycology, Journal of Antimicrobial Chemotherapy and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.